Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03231020 · ClinicalTrials.gov registry record
Parental Experience in the Single Ventricle Interstage Utilizing a mHealth Innovation: A Comparative Case Study
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 11
- Enrollment target
NCT03231020: Completed study, sponsored by Children's Mercy Hospital Kansas City.
NCT03231020 is a clinical trial that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03231020 has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to provide a rich description of the parental perspectives of utilizing a mHealth application for data transfer during the single ventricle interstage monitoring period. A gap in the body of knowledge of single ventricle cardiac disease interstage will be explored with these research questions: 1) How do parents of children (\< 5 years of age) with single ventricle disease describe their experiences using a mHealth application during the interstage period (first 6-12 months of child's life)? And 2) How do these experiences influence their decision making for use of the mHealth application?
Primary Outcome
parental perspective on interstage period will influence the number of Data days during the interstage period
Interventions
- OTHER Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-09-13 |
| Est. Completion | 2020-05-30 |
What the finished NCT03231020 record still lists
NCT03231020 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Interview is the first listed.
NCT03231020 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03231020 about?
NCT03231020 is a clinical study titled "Parental Experience in the Single Ventricle Interstage Utilizing a mHealth Innovation: A Comparative Case Study". The purpose of this study is to provide a rich description of the parental perspectives of utilizing a mHealth application for data transfer during the single ventricle interstage monitoring period. A gap in the body of knowledge of single ventricle cardiac disease interstage will be explored with t...
What is the current status of trial NCT03231020?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2019-09-13. Estimated completion is 2020-05-30.
What interventions are being tested in trial NCT03231020?
The interventions under investigation include: Interview (OTHER).
Who is sponsoring clinical trial NCT03231020?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI